Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

I Robertson

Showing results (61-70 of 666) with videos related to

Pageof 67
Sort By:
Cardiovascular Drugs and Therapy|September 22, 2000
Which antihypertensive drug classes have been shown to be beneficial? What are their benefits? A critique of hypertension treatment trialsJ I Robertson
British Heart Journal|September 1, 1994
Role of ACE inhibitors in uncomplicated essential hypertensionJ I Robertson
European Heart Journal|March 1, 1984
Diuretics, potassium depletion and the risk of arrhythmiasJ I Robertson
Journal of Cardiovascular Pharmacology|January 1, 1991
Serotonergic type-2 (5-HT2) antagonists: a novel class of cardiovascular drugsJ I Robertson
Journal of Cardiovascular Pharmacology|January 1, 1986
Circulatory basis for the use of angiotensin converting enzyme inhibitors in hypertension and cardiac failureJ I Robertson
C.I.C.I.A.M.S. Nouvelles|January 1, 1978
Doing something about high blood pressureJ I Robertson
Journal of Cardiovascular Pharmacology|January 1, 1987
Factors influencing treatment of hypertensionJ I Robertson
Clinical Science and Molecular Medicine. Supplement|December 1, 1978
Address on the occasion of the presentation of the Merck Sharp and Dohme International Award to Professor Jens Bing and his associates and the Franz Volhard Award to Professor Bjorn FolkowJ I Robertson
South African Medical Journal = Suid-Afrikaanse Tydskrif Vir Geneeskunde|July 18, 1981
Metoclopramide in the treatment of children's behaviour problemsL I Robertson
Clinical Science and Molecular Medicine. Supplement|December 1, 1978
Closing address: au revoir et à bientôtJ I Robertson
Pageof 67

Showing results (61-70 of 666) with videos related to

Sort By:
Pageof 67
Cardiovascular Drugs and Therapy|September 22, 2000
Which antihypertensive drug classes have been shown to be beneficial? What are their benefits? A critique of hypertension treatment trialsJ I Robertson
British Heart Journal|September 1, 1994
Role of ACE inhibitors in uncomplicated essential hypertensionJ I Robertson
European Heart Journal|March 1, 1984
Diuretics, potassium depletion and the risk of arrhythmiasJ I Robertson
Journal of Cardiovascular Pharmacology|January 1, 1991
Serotonergic type-2 (5-HT2) antagonists: a novel class of cardiovascular drugsJ I Robertson
Journal of Cardiovascular Pharmacology|January 1, 1986
Circulatory basis for the use of angiotensin converting enzyme inhibitors in hypertension and cardiac failureJ I Robertson
C.I.C.I.A.M.S. Nouvelles|January 1, 1978
Doing something about high blood pressureJ I Robertson
Journal of Cardiovascular Pharmacology|January 1, 1987
Factors influencing treatment of hypertensionJ I Robertson
Clinical Science and Molecular Medicine. Supplement|December 1, 1978
Address on the occasion of the presentation of the Merck Sharp and Dohme International Award to Professor Jens Bing and his associates and the Franz Volhard Award to Professor Bjorn FolkowJ I Robertson
South African Medical Journal = Suid-Afrikaanse Tydskrif Vir Geneeskunde|July 18, 1981
Metoclopramide in the treatment of children's behaviour problemsL I Robertson
Clinical Science and Molecular Medicine. Supplement|December 1, 1978
Closing address: au revoir et à bientôtJ I Robertson
Pageof 67